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Emerging evidence suggests that innate immunity drives alcoholic
liver disease (ALD) and that the interferon regulatory factor 3 (IRF3),
a transcription factor regulating innate immune responses, is in-
dispensable for the development of ALD. Here we report that IRF3
mediates ALD via linking endoplasmic reticulum (ER) stress with
apoptotic signaling in hepatocytes. We found that ethanol induced
ER stress and triggered the association of IRF3 with the ER adaptor,
stimulator of interferon genes (STING), as well as subsequent phos-
phorylation of IRF3. Activated IRF3 associated with the proapoptotic
molecule Bax [B-cell lymphoma 2 (Bcl2)-associated X protein] and
contributed to hepatocyte apoptosis. Deﬁciency of STING prevented
IRF3 phosphorylation by ethanol or ER stress, and absence of IRF3
prevented hepatocyte apoptosis. The pathogenic role of IRF3 in ALD
was independent of inﬂammation or Type-I interferons. Thus, STING
and IRF3 are key determinants of ALD, linking ER stress signaling
with the mitochondrial pathway of hepatocyte apoptosis.
steatohepatitis | Kupffer cells | stimulator of interferon genes |
interferon regulatory factor 3
Alcoholic liver disease (ALD) affects over 140 million peopleworldwide, and currently there is no effective treatment.
Acute alcohol consumption induces fatty liver and excessive al-
cohol use causes progression to steatohepatitis, cirrhosis, and
hepatocellular carcinoma. Dysregulation of innate immunity and
liver inﬂammation, triggered by the translocation of gut-derived
endotoxin [lipopolysaccharide (LPS)] to the liver, represent
major contributors to ALD (1). The recognition of gut-derived
LPS by Kupffer cells (KC) requires the Toll-like receptor 4
(TLR4), which triggers two downstream pathways. The TLR4/
myeloid differentiation primary response gene 88 (MyD88) path-
way activates transcription of inﬂammatory cytokines, whereas
TLR4/TRAM/TRIF [TIR domain-containing adaptor inducing
interferon-beta (TRIF)–related adaptor molecule (TRAM)] trig-
gers Type-I interferons (IFN) regulatory factor 3 (IRF3) to induce
IFN (2). The essential role of the TLR4 signaling in ALD was
demonstrated in mice lacking functional TLR4 that showed at-
tenuation of alcoholic steatohepatitis (3, 4). In previous studies, we
reported that the MyD88-dependent pathway was dispensable for
ALD (4) and observed complete protection from alcohol-induced
inﬂammation, steatosis, and injury in mice deﬁcient in IRF3 (5),
suggesting that the pathogenic effects of TLR4 in ALD were me-
diated via the TRAM/TRIF-dependent pathway. However, the
mechanisms by which IRF3 causes ALD remain obscure.
IRF3 is a constitutively expressed transcription factor that
resides in the cytoplasm and dimerizes and translocates to the
nucleus upon phosphorylation (6). Phosphorylated IRF3 induces
IFN-β during viral infection, but may also contribute to in-
ﬂammatory cytokine response to LPS (7). IRF3 also promotes
apoptosis in virus-infected cells through association with proa-
poptotic molecule Bax [B-cell lymphoma 2 (Bcl2)-associated X
protein] (8). To elucidate the mechanism by which IRF3 determines
ALD, we asked three fundamental questions. First, is the
pathogenic effect of IRF3 in the liver mediated by inﬂammatory
cytokines, Type-I IFNs, or other signals? Second, is IRF3 activated
by TLR4 or by other mechanisms in ALD? Third, is the pathogenic
role of IRF3 linked to KC or hepatocytes?
Here we show that IRF3 is activated early in ALD by endo-
plasmic reticulum (ER) stress, and this is mediated by the ER
adaptor, stimulator of interferon genes (STING). We also de-
monstrate that IRF3 exerts its pathogenic role in ALD by inducing
apoptosis of hepatocytes. Although IRF3 is a key component of the
innate immune response, our data demonstrate that IRF3 in ALD
acts independently of inﬂammatory cytokines and Type-I IFNs. Our
results identify a unique role of IRF3 as a signaling molecule me-
diating a cross-talk between the ER stress and hepatocyte apoptosis
and demonstrate an important role for STING in IRF3 phos-
phorylation in the liver.
Results
Pathogenic Role of IRF3 in ALD Is Independent of Inﬂammation and
Type-I IFN Signaling. IRF3 is indispensable for the development of
ALD (5), but the mechanisms underlying its pathogenic role are
not known. Here we asked whether the effects of IRF3 in ALD
are mediated by inﬂammatory signaling. Consistent with its role
in induction of TNF-α (7), deﬁciency of IRF3 completely pre-
vented liver inﬂammation induced by a 4-wk ethanol feeding in
mice (Fig. 1A, SI Appendix, Fig. S2E, and ref. 5). In addition,
IRF3-KO mice showed full protection from alcohol-induced
liver damage (Fig. 1B, SI Appendix, Fig. S2C, and ref. 5). The
extent of protection from liver damage in IRF3-KO mice was
superior to that observed in other strains deﬁcient in innate
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immune signaling. For example, interleukin (IL)-1 receptor (IL-
1R1) deﬁciency or absence of inﬂammasome components, ASC
or Caspase 1 (Casp-1), which are required for IL-1β maturation,
protected from liver inﬂammation (Fig. 1A and ref. 9) but only
partially attenuated alcoholic liver damage (Fig. 1B and ref. 9).
Interestingly, no protection from alcohol-induced liver in-
ﬂammation or acute or chronic liver injury was observed in mice
deﬁcient in TRAM (Fig. 1 A and B and SI Appendix, Fig. S1),
which bridges TLR4 with downstream signaling that induces
phosphorylation of IRF3 in immune cells (2).
The 4-wk model of ALD represents a compound outcome of
acute and chronic events. As IRF3 deﬁciency protected from
ALD after 4 wk (Fig. 1 A and B), we next sought to evaluate the
early phase of liver injury using a single intragastric dose of
ethanol. We observed that IRF3-KO mice were fully protected
from acute alcohol-induced liver injury (Fig. 1C), suggesting
early involvement of IRF3 in ALD. In contrast, blockade of IL-
1R1 or deﬁciency of Casp-1 provided little protection from acute
alcoholic liver injury (Fig. 1C). Notably, acute liver injury and
steatosis induced by a single dose of ethanol were not accom-
panied by inﬂammation (Fig. 1 D–F) and developed independent
of KC (Fig. 1G), a major source of inﬂammatory cytokines in the
liver. This data suggested that acute alcoholic liver injury and
steatosis require IRF3 but are independent of inﬂammation.
Based on our observations that both acute administration of
ethanol and chronic ethanol feeding signiﬁcantly induced IFN-β
in the liver and in the serum (Fig. 1 H and I and SI Appendix, Fig.
S2A), we asked whether the pathogenic role of IRF3 in ALD was
mediated by Type-I IFNs. We found that deﬁciency of the Type-I
IFN receptor (IFNAR1) failed to provide protection from acute
alcohol-induced liver injury (Fig. 1J) and from inﬂammation,
steatosis, or damage elicited by a chronic ethanol diet (SI Ap-
pendix, Fig. S2 I–K). There was no protection from ALD in mice
deﬁcient in IRF7 (SI Appendix, Fig. S2 F–H), a Type-I IFN-
inducing transcription factor distinct from IRF3 (2). Collectively,
these ﬁndings demonstrated that IRF3 determines pathology in
early in ALD, independently of inﬂammation or Type-I IFNs.
Our data also suggested that the signal for activation of IRF3 in
the early phase of alcohol-induced liver injury was not mediated
by TLR4/TRAM.
IRF3 Is Required for Apoptosis of Hepatocytes. The unexpected
ﬁnding of inﬂammation- and Type-I IFN-independent role of
IRF3 in alcohol-induced liver damage directed our attention to
the recently described proapoptotic role of IRF3 (8). We hy-
pothesized that IRF3 partners with Bax to translocate to mito-
chondria and initiate hepatocyte apoptosis. We further postulated
that should this mechanism occur in the liver, IRF3 would be
present in hepatocytes and interact with components of apoptotic
signaling. Further, we predicted that IRF3 in hepatocytes them-
selves would drive development of ALD.
We found Irf3mRNA both in liver mononuclear cells (LMNCs)
and in hepatocytes (Fig. 2A) and observed that administration of
a single dose of ethanol to WT mice resulted in phosphorylation
of IRF3 in hepatocytes (Fig. 2B), indicating activation of hepa-
tocyte-speciﬁc IRF3 in ALD. Phosphorylation of IRF3 in the
liver occurred early after a single dose of alcohol (Fig. 2C), which
preceded the development of signiﬁcant liver injury and steatosis
(Fig. 1D), and was accompanied by cleavage of Casp-3 and Casp-
8 and by apoptosis in the liver (Fig. 2 D and E). Notably, we
found that following ethanol administration, IRF3 associated
with the apoptosis-initiating Casp-8 and with the mitochondria-
permeabilizing protein Bax in the liver (Fig. 2F). Together, these
data demonstrated that early after administration of ethanol,
IRF3 is activated and interacts with the apoptotic signaling
pathway in the liver, leading us to hypothesize that IRF3 regu-
lates apoptosis in hepatocytes.
We further investigated whether IRF3 was required for hepatocyte
apoptosis using the Fas cell surface death receptor (Fas)-activating
anti-CD95 antibody, clone Jo2 (Jo2). Hepatocytes have a pro-
nounced susceptibility to Fas-mediated apoptosis, and we ob-
served a signiﬁcant increase of the Fas ligand (FasL) in the livers
and serum of alcohol-treated mice (SI Appendix, Fig. S3A).
Administration of Jo2 in WT mice resulted in early phosphory-
lation of IRF3 in the liver (SI Appendix, Fig. S3B), followed by
apoptosis and liver injury (SI Appendix, Fig. S3 B–D). Impor-
tantly, we found that IRF3-KO mice were fully protected from
Jo2-induced liver damage (Fig. 3 A and C), hepatocyte apoptosis
(Fig. 3B), and mortality (Fig. 3E), and this protection was ac-
companied by the lack of cleavage of Casp-8, Casp-3, and poly
(ADP-ribose) polymerase 1 (PARP) in the liver (Fig. 3D). In
Fig. 1. The pathogenic role of IRF3 in ALD is in-
dependent of inﬂammation and Type-I IFN signal-
ing. Mice of indicated genotypes were fed an
alcohol diet and killed 4 wk later. Liver inﬂammation
was assessed by TNF-α mRNA (A), and liver injury
was evaluated by serum alanine aminotransferase
(ALT) (B). The numbers indicate the extent by
which deﬁciency of a speciﬁc gene protects from
alcohol-induced increase in TNF-α or ALT; −100%
indicates full protection. Source data are shown in
SI Appendix, Figs. S1 A and C and S2 C and E, and
ref. 9. (C) A single dose of ethanol (5 g/kg) was
administered to WT, Casp1-KO, IRF3-KO, or IL-
1R1-KO mice or to WT mice pretreated i.p. with IL-
1 receptor antagonist (IL-1Ra), and serum ALT was
measured. (D–F) WT mice received a single dose
of ethanol, and liver injury, steatosis, and in-
ﬂammation were evaluated using histology (D),
ALT (E), and expression of Tnfa, pro-Il-1b, and
Mcp1 (F). WT mice received i.v. clodronate. Two
days later, depletion of KC in the liver was veriﬁed
by F4/80, ethanol was administered, and serum
ALT was measured (G). WT mice received a single
dose of ethanol, and liver Ifnb and serum IFN-β
were evaluated (H and I). WT or IFNAR1-KO mice
received a single dose of ethanol. Liver injury was
evaluated by ALT (J). n = 5–8 mice per group (C–J).
*P < 0.05 vs. baseline. (Magniﬁcation, 200×.)









contrast to IRF3-KO animals, no protection from Jo2-induced
liver damage or apoptosis was observed in mice deﬁcient in
IFNAR1 (Fig. 3 F–I). Finally, we observed complete protection
from Jo2-mediated apoptosis in primary hepatocytes isolated
from IRF3-KO mice (Fig. 3 J and L) and in WT hepatocytes
treated with BX795 (Fig. 3 K and M), an inhibitor of IRF3
phosphorylation (10). Consistent with these ﬁndings, induction
of IRF3 phosphorylation accelerated hepatocyte apoptosis trig-
gered by Jo2 (SI Appendix, Fig. S4C). In contrast, primary hep-
atocytes isolated from IFNAR1- or IRF7-KOmice were susceptible
to Jo2-induced cell death to an extent comparable to WT hep-
atocytes (Fig. 3J).
Collectively, these data demonstrated that IRF3 is expressed in
hepatocytes and is required for hepatocyte apoptosis in response to
alcohol. Our results demonstrate that the pathogenic effect of
IRF3 in ALD is mediated by intrinsic IRF3-dependent hepatocyte
apoptosis and is independent of the role of IRF3 in inﬂammatory
or Type-I IFN responses and provide explanation for the superior
protection from ALD in IRF3-KO mice compared with strains
deﬁcient in other components of innate immune signaling.
IRF3 Associates with the Endoplasmic Reticulum Adaptor, STING, in
the Liver. Next, we sought to identify the mechanism of IRF3
activation in ALD. Given our initial ﬁndings (Fig. 1A and SI
Appendix, Fig. S1), we hypothesized that a TRAM-independent
mechanism was responsible for IRF3 activation. Although ad-
ministration of Jo2 induced phosphorylation of IRF3 in the liver
(SI Appendix, Fig. S3B), we rejected the hypothesis that Fas
signaling would be a major source of early IRF3 activation in
ALD because up-regulation of FasL in the liver occurred late
after ethanol administration (4 h, SI Appendix, Fig. S3A).
Analysis of the baseline distribution of IRF3 in mouse livers
revealed that IRF3 was present not only in the cytoplasm but
also in mitochondrial and ER extracts (SI Appendix, Fig. S5A).
To study the functional signiﬁcance of this ﬁnding, we analyzed
the subcellular localization of IRF3 after a single dose of ethanol
Fig. 2. IRF3 is activated in hepatocytes and associates with components of apoptotic signaling in ALD. (A) Mononuclear cells (LMNCs) or hepatocytes (Hep.)
were isolated from the livers of WT mice, and expression of the Irf3 was evaluated. (B) WT mice were administered a single dose of ethanol. Two hours
afterward, hepatocytes were isolated, and phospho-IRF3 was analyzed. (C–F) WT mice were administered a single dose of ethanol and phosphorylation of IRF3
(C), apoptosis (D), and cleavage of Casp-8 and Casp-3 (E), and association of IRF3 with Casp-8 or Bax (F) was analyzed in the liver. n = 11mice per cell type (A); n = 3
mice per treatment (B); and n = 6 mice per time point (C–F). Arrows in D indicate TUNEL+ nuclei. *P < 0.05 vs. baseline. (Original magniﬁcation, 400×.)
Fig. 3. IRF3 is required for apoptosis of hepatocytes.
WT or IRF3-KO mice received a single i.p. dose of Jo2
(0.5 mg/kg) or saline and were killed after 8 h (A–D)
or were evaluated for survival (E). In another ex-
periment, 0.5 mg/kg Jo2 or saline was administered
to WT or IFNAR1-KO mice (F–I). Liver injury was
evaluated by H&E (A and F) and by serum ALT (C and
H). Apoptosis was evaluated by TUNEL (B and G) and
by cleavage of PARP, Casp-3, and Casp-8 in the liver
(D and I). Primary hepatocytes were isolated from
WT, IRF7-KO, IFNAR1-KO, or IRF3-KO mice and ex
vivo treated with Jo2 for 8 h (J–M). Some WT hep-
atocytes were pretreated for 30 min with BX795
(K and M). Hepatocyte death was evaluated by lac-
tate dehydrogenase (LDH) (J and K) or cytochrome c
in the supernatant (L andM). n = 7 (Jo2-treated, per
genotype), and n = 3 (saline-treated, per genotype)
in A–D; n = 5–6 (Jo2-treated, per genotype), and
n = 3 (saline treated, per genotype) in F–I; and n = 24
(WT), and n = 13 (IRF3-KO) in E. Experiments in J–M
were performed in triplicate. Numbers in the graphs
indicate P values. *P < 0.05 vs. baseline. Densito-
metric analysis for Fig. 3 D and I is shown in SI Ap-
pendix, Fig. S4 A and B. (Original magniﬁcation,
200×.)
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and found that phosphorylation of IRF3 was detected in the
whole-cell liver extract (Fig. 4A), cytoplasm (SI Appendix, Fig.
S5C), nucleus (Fig. 4B), ER (Fig. 4C), and mitochondria (Fig.
4D). The presence of phospho-IRF3 in the nucleus (Fig. 4B) was
consistent with the transcriptional role of activated IRF3 (7) and
the early alcohol-induced Ifnb (Fig. 1H). The presence of phos-
pho-IRF3 in the mitochondria (Fig. 4D) further supported the
involvement of IRF3 in the mitochondrial pathway of hepatocyte
apoptosis (Figs. 2 and 3).
The ﬁnding of phospho-IRF3 in the liver ER (Fig. 4C) was
unexpected and prompted us to search for implications of this
phenomenon. It has been reported that ER serves as a platform
for activation of IRF3 by cytosolic RNA or DNA of viral origin
and that during certain viral infections, IRF3 associates with ER
via binding to Stimulator of IFN genes (STING, also known as
TMEM173 or MPYS), an adaptor molecule residing in the ER
membrane (11). To explore whether interaction between IRF3
and STING occurred in the liver, we performed immunopre-
cipitation and found that following administration of ethanol,
IRF3 associated with STING in the whole-cell liver lysate (Fig.
4E) and in the ER extract (Fig. 4G). IRF3 also bound to phos-
pho-TBK1 [TRAF family member-associated NFκB activator
(TANK)-binding kinase] (Fig. 4 E and G), which is a kinase
required for IRF3 phosphorylation (11). Notably, the association
of IRF3 with STING or p-TBK1 in the ER occurred rapidly after
alcohol administration (Fig. 4G), at the same time point as the
binding of IRF3 to Bax (Fig. 2F). Interestingly, although STING
is also present in the outer mitochondrial membrane (13), we did
not see any association between IRF3 and STING or TBK1 in the
liver mitochondrial fraction (Fig. 4F). These ﬁndings demonstrated
that early after ethanol administration, IRF3 interacts with the
adaptor, STING, in the ER and raised the question of whether ER
stress was a trigger for IRF3 phosphorylation in ALD.
ER Stress Activates IRF3 in the Liver via the Adaptor, STING.A variety
of stressors perturb ER function in ALD, including oxygen
deprivation, dysregulation of calcium signaling, and accumula-
tion of misfolded proteins (12). These events, collectively labeled
as ER stress, initiate homeostatic responses but also contribute
to liver pathology. We found that administration of a single dose
of ethanol induced early ER stress in the liver, as demonstrated
by splicing of Xbp1 mRNA (sXbp1) (Fig. 5A), a component of
the ER stress-associated response (12). Analysis of cell pop-
ulations in the liver demonstrated that increased splicing of Xbp1
occurred in hepatocytes but not in LMNC of mice exposed to
acute alcohol (Fig. 5B), which was consistent with the dominant
role of hepatocytes in ethanol metabolism. Further, we found
that treatment of primary hepatocytes with ethanol resulted in
ER stress independently of acetaldehyde (SI Appendix, Fig. S6),
which is consistent with previously published evidence indicating
that the pathogenic effects of ethanol are mediated by cyto-
chrome P450 independently of acetaldehyde (14).
We observed that induction of ER stress by thapsigargin eli-
cited early phoshorylation of IRF3 (Fig. 5 C and E) and death
(Fig. 5D) in primary mouse hepatocytes. We conﬁrmed the re-
quirement of IRF3 activation for ER stress-induced cytotoxicity
using BX795, an inhibitor of IRF3 phosphorylation, which
inhibited hepatocyte death (Fig. 5D). Next, we observed that
thapsigargin failed to induce IRF3 phosphorylation in hepatocytes
isolated from the transmembrane protein 173 (Tmem173)gt mice
(Fig. 5E), which lack the STING protein. This ﬁnding indicated
that activation of IRF3 in hepatocytes by ER stress is dependent
on STING.
To further evaluate the contribution of STING to IRF3
phosphorylation in ALD, we administered a single dose of eth-
anol to WT or Tmem173gt mice and found that deﬁciency of
STING completely protected mice from acute liver injury (Fig.
5F), similar to the protection observed in IRF3-KO animals (Fig.
1C). To deﬁne the importance of STING in chronic ALD, we fed
an ethanol or control diet to WT and Tmem173gt mice. In contrast
to WT mice, Tmem173gt mice failed to phosphorylate IRF3 in the
liver (Fig. 5G) and did not cleave Casp-3 indicating absence of
alcohol-induced apoptosis (Fig. 5H). Further, Tmem173gt mice
showed normalization of the morphological features of ALD and
absence of steatosis upon histological analysis (Fig. 5 I and J).
Consistent with the absent phosphorylation of IRF3 in the liver,
alcohol-fed Tmem173gt mice failed to up-regulate Ifnb and did not
show induction of Isg15, a marker of Type-I IFN signaling (Fig.
5L) after ethanol feeding. We observed that Tmem173gt mice
were signiﬁcantly protected from alcohol-induced liver injury only
at early time points (Fig. 5 F and K) but not at the conclusion of
the experiment (day 14 in Fig. 5K). We hypothesize that the lack
of protection from late alcohol liver damage in Tmem173gt mice
was attributable to the up-regulation of inﬂammatory cytokines
(SI Appendix, Fig. S7), which have not been reported to be con-
trolled by STING-dependent signaling. Importantly, our data
demonstrated that activation of IRF3 in ALD is triggered by the
ER stress in hepatocytes via the adaptor, STING. Thus, STING
and IRF3 are key determinants of ALD, linking ER stress sig-
naling with the mitochondrial pathway of hepatocyte apoptosis.
Fig. 4. IRF3 associates with the endo-
plasmic reticulum adaptor, STING, in the
liver. WT mice received a single dose of
ethanol. At indicated time points, mice
were killed, and phosphorylation of IRF3
was assessed by immunoblotting in liver
whole-cell (A), nuclear (B), ER (C), and
mitochondrial (D) extracts. Using immu-
noprecipitation with antitotal IRF3 anti-
body for protein pull-down, we evaluated
association between total IRF3 and STING
or phosphorylated TBK1 in the whole-cell
(E), mitochondrial (F), and ER (G) extracts.
n = 3 per time point. *P < 0.05 vs. base-
line. Densitometric analysis for Fig. 4 E–G
is shown in SI Appendix, Fig. S4B.










Innate immunity and inﬂammation are involved in alcoholic
steatohepatitis, cirrhosis, and hepatocellular cancer. These en-
tities represent advanced stages of ALD and develop only in
a subset of alcohol-drinking individuals (1). However, it is not
known whether innate immune signaling is also involved in the
early stage of ALD which is characterized by simple steatosis and
mild hepatocyte injury. Here we demonstrated that innate im-
mune signaling is a major determinant of early ALD, even before
the onset of inﬂammation. We provide unique evidence that
IRF3, an essential component of innate immunity, is activated by
ER stress via the adaptor molecule STING and that IRF3 is
required for apoptosis of hepatocytes. Thus, we have identiﬁed
a unique role of STING and IRF3 in coupling ER stress with
mitochondrial death signaling in ALD.
Our study provides several lines of evidence that IRF3 deter-
mines early ALD without the involvement of inﬂammation. First,
IRF3 was present in hepatocytes where it underwent phosphor-
ylation shortly after a single exposure to ethanol, before the de-
velopment of inﬂammation. Second, IRF3 was activated by the
ER stress in hepatocytes via the adaptor, STING. Third, IRF3
was required for hepatocyte apoptosis. Finally, IRF3 determined
the early stage of ALD independent of inﬂammatory cytokine-
producing KC or Type-I IFN signaling. Although KC are required
for alcoholic steatohepatitis (1), our results demonstrate that the
early phase of ALD is driven by hepatocyte-speciﬁc IRF3 rather
than KC-dependent inﬂammation. Phosphorylation of IRF3 in
hepatocytes occurred within 30 min after induction of ER stress,
and IRF3 associated with STING, phospho-TBK1, and Bax in less
than 2 h after administration of ethanol in the absence of liver
inﬂammation. The dispensability of inﬂammation for these early
events was further supported by the development of acute alco-
hol-induced liver injury in mice depleted of KC. Our data are
consistent with ﬁndings that liver inﬂammation develops late after
prolonged exposure to alcohol (15). Hepatocyte-speciﬁc IRF3 is
key to ALD, whereas the contribution of myeloid cell-speciﬁc
IRF3 to ALD is minor, as demonstrated by our previous data
showing that deﬁciency of IRF3 in KC prevented up-regulation of
TNF-α in the chronic model of ALD but provided only marginal
protection from liver damage (5).
Fig. 5. ER stress activates IRF3 in the
liver via the adaptor, STING. WT mice
received a single dose of ethanol.
Splicing of Xbp1 mRNA (sXBP1) in the
liver was evaluated by PCR, and ex-
pression of total Xbp1 in the liver was
measured by qPCR (A). WT mice re-
ceived a single dose of ethanol. After
2 h, hepatocytes or LMNCs were iso-
lated and analyzed for sXBP1 (B). Pri-
mary hepatocytes isolated from WT
mice were treated with thapsigargin and
analyzed for phospho-IRF3 (C). Some
hepatocytes were pretreated with BX795
and analyzed for cytotoxicity by measur-
ing LDH in supernatants (D). Primary hep-
atocytes isolated from WT or Tmem173gt
mice were stimulated with thapsigargin
and analyzed for phospho-IRF3 and for
GRP78 indicating ER stress (E). WT or
Tmem173gt mice received a single dose of
ethanol, and liver injury was evaluated by
serum ALT (F). WT or Tmem173gt mice
were fed a control or alcohol diet. After 2
wk, we evaluated phospho-IRF3 (G),
cleavage of Casp-3 in the liver (H), lipid
accumulation (I and J), histology (I), and
serum ALT (K). Expression of Ifnb1 and
Isg15wasevaluatedbyqPCR (L).n=3mice
per time point and genotype inA–E; and n
= 10–15mice (ethanol-fed, per genotype),
and n = 3–6 mice (pair-fed, per genotype)
in F–L. Numbers in the graphs indicate P
values. *P < 0.05 vs. baseline. (Original
magniﬁcation, 200×.) Vertical line in C
divides two noncontiguous parts of the
same blot. (M) The role of IRF3 in the
pathogenesis of ALD. In the acute setting,
alcohol-induced ER stress in hepatocytes
triggers association of IRF3 with the ER
adaptor, STING. Serving as a molecular
scaffold, STING facilitates phosphoryla-
tion of IRF3 by phospho-TBK1 (a). Sub-
sequently, phospho-IRF3 associates with
Bax and triggers mitochondrial pathway
of hepatocyte apoptosis (b). This path-
way represents themajormechanismof IRF3-inducedpathology inALDand is independentof inﬂammationorType-I IFNs. In chronicALD,phospho-IRF3also induces
Type-I IFNs in hepatocytes, which have antiﬁbrotic and anti-inﬂammatory effects (c). Phosphorylation of IRF3 is augmented by FasL (d). Induction of inﬂammatory
cytokines by phospho-IRF3 does not play a role in acute ALD. In the chronic ALD, phospho-IRF3 in KC is required for induction of TNF-α, but only marginally con-
tributes to liver pathology (e).
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Given the increased gut permeability induced by ethanol (1),
we initially hypothesized that LPS would activate IRF3 in ALD,
but in kinetic studies we found that serum endotoxin peaked
after the alcohol-induced phosphorylation of IRF3 in the liver
had already been established (SI Appendix, Fig. S8 and Fig. 2C).
Instead, our data demonstrate that the signal to trigger phos-
phorylation of IRF3 in early ALD comes from the ER and is
dependent on STING. STING is predominantly associated with
ER, where it enables IRF3 phosphorylation by TBK1 in the
cytosolic dsDNA-signaling pathway, but it is also present on the
outer mitochondrial membrane to facilitate the retinoic acid-
inducible gene I pathway activated by viral RNA (10). We found
that although IRF3 phosphorylated in ER and mitochondria, it
associated with STING and phospho-TBK1 only in ER, but not
in mitochondria. Therefore, we hypothesize that early in ALD,
IRF3 is phosphorylated by the ER-associated STING aided by
TBK1 and translocates to the mitochondria along with Bax to
initiate hepatocyte apoptosis. Although our data demonstrate
that the activation of IRF3 by STING is initiated by ER stress,
we cannot rule out other potential activators of STING, in
particular cytosolic dsDNA, which activates STING via cGMP-
AMP synthase (cGAS) (16). As cGAS recognizes both bacterial
and host dsDNA, we cannot exclude the possibility that DNA,
released from the nuclei of damaged hepatocytes, activates STING
and IRF3. We speculate that should this phenomenon occur in the
liver, it would probably contribute to the later phase of ALD. In-
vestigation of mechanisms other than ER stress that might be in-
volved in STING activation in early ALD is beyond the scope of
this study. Although deﬁciency of IRF3 or STING prevented lipid
accumulation in hepatocytes in our model (SI Appendix, Fig. S2 C
andD and Fig. 5 I and J), it has been shown that chemical induction
of ER stress directly contributed to hepatocyte steatosis via
a mechanism involving sXBP1 (17), which has not been reported to
interact with STING or IRF3. Thus, it is likely that multiple
pathways downstream of ER mediate alcohol-induced hepatocyte
pathology, and their relative contribution to early ALD remains to
be determined.
Based on our data, we propose that the major pathogenic
effect of IRF3 in early ALD is hepatocyte-speciﬁc and that it
occurs within the ﬁrst few hours after alcohol ingestion in re-
sponse to ER stress and STING and is mediated by hepatocyte
apoptosis (Fig. 5M). Other mechanisms of IRF3 activation, e.g.,
IRF3 phosphorylation induced by the TLR4 pathway in KC or by
Fas ligand upon hepatocytes, occur at a later stage and may
contribute to ampliﬁcation of liver damage and development of
liver inﬂammation but are unlinked from STING-IRF3-Bax–
driven liver injury. From the therapeutic perspective, a cautious
approach should be used with inhibitors of IRF3. Although not
required for the pathogenic role of IRF3 in ALD, Type-I IFNs
are protective in liver inﬂammation induced by TLR9 and are
required for induction of the anti-inﬂammatory IL-10 in chronic
ALD, as we previously reported (5, 18). Also, Type-I IFNs have
an inhibitory role in liver ﬁbrosis (18). Therefore, it would be
desirable to design molecules that would suppress the proa-
poptotic role and spare the Type-I IFN-inducing capability of
IRF3. This could be theoretically possible, as the transcriptional
and the proapoptotic domains of IRF3 are distinct and located
on the opposite termini of the molecule (8).
Based on our data, activation of IRF3 and induction of he-
patocyte apoptosis is a highly reproducible response to chronic
and even a single ethanol exposure. Although human alcoholics
consume alcohol chronically, alcohol-drinking patterns often in-
clude acute binges in the chronic alcohol use setting, suggesting
that the phenomenon observed in our animal model may also
occur in humans. However, testing for this in humans is technically
difﬁcult because there are no sufﬁcient serum markers for IRF3
activation. We hypothesize that if the alcohol exposure events are
sufﬁciently spaced out, hepatocyte apoptosis may be a self-limiting
phenomenon. However, alcohol binges in close succession, as
occurs in chronic alcoholics, may result in overlapping waves of
hepatocyte death associated with the release of hepatocyte-de-
rived damage-associated molecular patterns which are required
for inﬂammation and advanced stages of ALD.
Taken together, our results identify a unique role of IRF3 and
STING as signaling molecules mediating cross-talk between the
ER stress and apoptosis in hepatocytes. To the best of our
knowledge, we show for the ﬁrst time that activation of IRF3 by
STING and induction of cell death by IRF3, originally reported
in the context of antiviral response (8, 10), occur in hepatocytes,
an essentially metabolic cell type. Our data suggest that innate
immune mechanisms regulate a response to acute, inﬂammation-
independent derangements in hepatocyte biology induced by
ethanol. The purpose of this biological principle awaits further
elucidation.
Methods
Information on animal studies, Kupffer-cell depletion protocol, cytokine
measurement, protein and RNA quantiﬁcation, histological analysis, in vitro
experiments, and statistics is provided in SI Appendix. All P-values are 2-sided.
All animals received proper care in agreement with animal protocols approved
by the Institutional Animal Use and Care Committee of the University of
Massachusetts Medical School.
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